Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O M Wolkowitz

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|August 1, 1989
Alprazolam augmentation of neuroleptics in schizophreniaO M Wolkowitz, A Breier, A Doran, et al.
Biological Psychiatry|July 1, 1999
Antiglucocorticoid treatment of depression: double-blind ketoconazoleO M Wolkowitz, V I Reus, T Chan, et al.
Archives of General Psychiatry|November 1, 1988
Early parental loss and development of adult psychopathologyA Breier, J R Kelsoe, P D Kirwin, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
The American Journal of Psychiatry|December 1, 1987
Neuroleptic responsivity of negative and positive symptoms in schizophreniaA Breier, O M Wolkowitz, A R Doran, et al.
Archives of General Psychiatry|February 1, 1987
Clinical and biochemical effects of verapamil administration to schizophrenic patientsD Pickar, O M Wolkowitz, A R Doran, et al.
Psychopharmacology Bulletin|January 1, 1988
Prednisone-induced behavioral and biological changes in medically healthy volunteersO M Wolkowitz, A Breier, A Doran, et al.
Psychoneuroendocrinology|January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humansO M Wolkowitz, N M Papadopoulos, R Costello, et al.
The New England Journal of Medicine|August 1, 1985
Effect of naloxone on food consumption in obesityO M Wolkowitz, A R Doran, M R Cohen, et al.
Biological Psychiatry|August 1, 1988
Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effectsO M Wolkowitz, A R Doran, M R Cohen, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|August 1, 1989
Alprazolam augmentation of neuroleptics in schizophreniaO M Wolkowitz, A Breier, A Doran, et al.
Biological Psychiatry|July 1, 1999
Antiglucocorticoid treatment of depression: double-blind ketoconazoleO M Wolkowitz, V I Reus, T Chan, et al.
Archives of General Psychiatry|November 1, 1988
Early parental loss and development of adult psychopathologyA Breier, J R Kelsoe, P D Kirwin, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
The American Journal of Psychiatry|December 1, 1987
Neuroleptic responsivity of negative and positive symptoms in schizophreniaA Breier, O M Wolkowitz, A R Doran, et al.
Archives of General Psychiatry|February 1, 1987
Clinical and biochemical effects of verapamil administration to schizophrenic patientsD Pickar, O M Wolkowitz, A R Doran, et al.
Psychopharmacology Bulletin|January 1, 1988
Prednisone-induced behavioral and biological changes in medically healthy volunteersO M Wolkowitz, A Breier, A Doran, et al.
Psychoneuroendocrinology|January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humansO M Wolkowitz, N M Papadopoulos, R Costello, et al.
The New England Journal of Medicine|August 1, 1985
Effect of naloxone on food consumption in obesityO M Wolkowitz, A R Doran, M R Cohen, et al.
Biological Psychiatry|August 1, 1988
Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effectsO M Wolkowitz, A R Doran, M R Cohen, et al.
Pageof 10